Literature DB >> 26887508

[Transforming growth factor-β1 induces bone marrow-derived mesenchymal stem cells to differentiate into cancer-associated fibroblasts].

Lei Shangguan1, Xiaojie Li2, Zhe Wang2, Zhuojing Luo2.   

Abstract

OBJECTIVE: To investigate the effect of transforming growth factor-β1 (TGF-β1) on the differentiation of bone marrow-derived mesenchymal stem cells (MSCs) into cancer-associated fibroblasts(CAFs).
METHODS: MSCs were cultured in α-MEM with recombinant human TGF-β1 or in tumor-conditioned medium.The expression of CAFs markers were detected by immunofluorescence and quantitative RT-PCR.
RESULTS: The qRT-PCR assay showed that the expression of CAFs markers FAP, ACTA, CAV, CCL5, CXCR4, FSP1, SDF-1 and vimentin were 9.92±2.16, 7.76±1.28, 3.04±0.95, 3.28±2.16, 2.13±0.71, 1.41±0.66, 2.25±0.86 and 1.38±0.56, respectively, significantly upregulated in the MSCs co-cultured with TGF-β1 or TCM. The relative levels of FAP, ACTA, CAV, CCL5, CXCR4, FSP1, SDF-1 and vimentin mRNA in the TCM group were 7.52±1.76, 5.02±1.18, 1.98±1.19, 1.82±1.19, 2.95±0.86, 1.44±0.67, 2.08±0.74 and 1.47±0.55, respectively, indicating that MSCs can express CAFs phenotype.TGF beta signaling pathway inhibitor SB-431542 could inhibit the differentiation. Both immunofluorescence and Western blot confirmed the above results.
CONCLUSIONS: TGF-β1 induces differentiation of local MSCs to CAFs by upregulating the expression of pSmad3, so as to further promote the growth of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26887508

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  3 in total

Review 1.  Into the eyes of bone marrow-derived mesenchymal stem cells therapy for myocardial infarction and other diseases.

Authors:  Jian-Rui Li; Ting-Ting Qu
Journal:  Stem Cell Investig       Date:  2017-08-23

2.  Bone marrow stem cells therapy alleviates vascular injury in a chronic obstructive pulmonary disease‑obstructive sleep apnea overlap syndrome rat model.

Authors:  Hong Bi; Jian He; Xu He; Junyi Du; Min Chen; Zhaoming Huang; Chao Yang; Lijuan Yang; Hang Li; Kaihua Zhou; Qing Wang; Lewei He; Zhixian Jin
Journal:  Mol Med Rep       Date:  2020-11-25       Impact factor: 2.952

3.  Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype.

Authors:  Roshanak Derakhshandeh; Sonia Sanadhya; Kyu Lee Han; Haiyan Chen; Olga Goloubeva; Tonya J Webb; Rania H Younis
Journal:  Oncotarget       Date:  2018-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.